BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 26369511)

  • 1. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.
    Wattjes MP; Rovira À; Miller D; Yousry TA; Sormani MP; de Stefano MP; Tintoré M; Auger C; Tur C; Filippi M; Rocca MA; Fazekas F; Kappos L; Polman C; Frederik Barkhof ; Xavier Montalban ;
    Nat Rev Neurol; 2015 Oct; 11(10):597-606. PubMed ID: 26369511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
    Rovira À; Wattjes MP; Tintoré M; Tur C; Yousry TA; Sormani MP; De Stefano N; Filippi M; Auger C; Rocca MA; Barkhof F; Fazekas F; Kappos L; Polman C; Miller D; Montalban X;
    Nat Rev Neurol; 2015 Aug; 11(8):471-82. PubMed ID: 26149978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
    Wattjes MP; Ciccarelli O; Reich DS; Banwell B; de Stefano N; Enzinger C; Fazekas F; Filippi M; Frederiksen J; Gasperini C; Hacohen Y; Kappos L; Li DKB; Mankad K; Montalban X; Newsome SD; Oh J; Palace J; Rocca MA; Sastre-Garriga J; Tintoré M; Traboulsee A; Vrenken H; Yousry T; Barkhof F; Rovira À; ; ;
    Lancet Neurol; 2021 Aug; 20(8):653-670. PubMed ID: 34139157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics.
    Leist TP; Marks S
    Neurology; 2010 Jan; 74 Suppl 1():S54-61. PubMed ID: 20038764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.
    Sastre-Garriga J; Pareto D; Battaglini M; Rocca MA; Ciccarelli O; Enzinger C; Wuerfel J; Sormani MP; Barkhof F; Yousry TA; De Stefano N; Tintoré M; Filippi M; Gasperini C; Kappos L; Río J; Frederiksen J; Palace J; Vrenken H; Montalban X; Rovira À;
    Nat Rev Neurol; 2020 Mar; 16(3):171-182. PubMed ID: 32094485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis].
    Rovira A; Tintoré M; Alvarez-Cermeño JC; Izquierdo G; Prieto JM
    Neurologia; 2010 May; 25(4):248-65. PubMed ID: 20609303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis.
    Bakshi R; Hutton GJ; Miller JR; Radue EW
    Neurology; 2004 Dec; 63(11 Suppl 5):S3-11. PubMed ID: 15596734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging advances in multiple sclerosis.
    Bakshi R
    J Neuroimaging; 2005; 15(4 Suppl):5S-9S. PubMed ID: 16385014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring.
    Traboulsee A; Létourneau-Guillon L; Freedman MS; O'Connor PW; Bharatha A; Chakraborty S; Girard JM; Giuliani F; Lysack JT; Marriott JJ; Metz LM; Morrow SA; Oh J; Sharma M; Vandorpe RA; Vertinsky TA; Wadhwa VS; von Riedemann S; Li DK
    Can J Neurol Sci; 2015 May; 42(3):159-67. PubMed ID: 25896163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance imaging in multiple sclerosis].
    Tourbah A; Berry I
    Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis.
    Filippi M; Horsfield MA; Adèr HJ; Barkhof F; Bruzzi P; Evans A; Frank JA; Grossman RI; McFarland HF; Molyneux P; Paty DW; Simon J; Tofts PS; Wolinsky JS; Miller DH
    Ann Neurol; 1998 Apr; 43(4):499-506. PubMed ID: 9546332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No].
    Edan G
    Rev Neurol (Paris); 2013 Nov; 169(11):864-8. PubMed ID: 24125462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs.
    Sormani MP; Bonzano L; Roccatagliata L; De Stefano N
    Mult Scler; 2011 May; 17(5):630-3. PubMed ID: 21177320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging in multiple sclerosis: the role of conventional imaging.
    Sicotte NL
    Neurol Clin; 2011 May; 29(2):343-56. PubMed ID: 21439445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
    Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
    Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A regional consensus recommendation on brain atrophy as an outcome measure in multiple sclerosis.
    Alroughani R; Deleu D; El Salem K; Al-Hashel J; Alexander KJ; Abdelrazek MA; Aljishi A; Alkhaboori J; Al Azri F; Al Zadjali N; Hbahbih M; Sokrab TE; Said M; Rovira À
    BMC Neurol; 2016 Nov; 16(1):240. PubMed ID: 27881095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI in the Diagnosis and Monitoring of Multiple Sclerosis: An Update.
    Wattjes MP; Steenwijk MD; Stangel M
    Clin Neuroradiol; 2015 Oct; 25 Suppl 2():157-65. PubMed ID: 26198879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.
    Filippi M; Rocca MA; Ciccarelli O; De Stefano N; Evangelou N; Kappos L; Rovira A; Sastre-Garriga J; Tintorè M; Frederiksen JL; Gasperini C; Palace J; Reich DS; Banwell B; Montalban X; Barkhof F;
    Lancet Neurol; 2016 Mar; 15(3):292-303. PubMed ID: 26822746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relevance of Magnet Resonance Tomography in the Diagnosis and Assessment of Course of Disease in Patients with Multiple Sclerosis].
    Lukas C; Sailer M
    Fortschr Neurol Psychiatr; 2015 Sep; 83(9):522-32; quiz 533-4. PubMed ID: 26421860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.